Exactech, Inc. EXAC
Set alert
At close · Jun 28
- Open
- 49.25
- Prev close
- 49.25
- Mkt cap
- 710.38M
- Vol
- 0
- Avg vol
- 134.36K
- EPS
- 0.026
- P/E
- 1894.23
- Div yield
- 0.00%
More statistics
- Low
- 49.25
- High
- 49.25
- Forward P/E
- 34.93
- Beta
- 0.39
- Short ratio
- 0.45
- Inst. own
- 53.58%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 20, 2018
- 50-d avg
- 49.39
- 200-d avg
- 42.89
- 1y target
- 49.00
Key statistics
- Market cap
- 710.38M
- Enterprise value
- 710.53M
- Trailing P/E
- 1894.23
- Forward P/E
- 34.93
- PEG ratio
- 0.00
- Price / sales
- 2.69
- Price / book
- 2.83
- EPS (TTM)
- 0.026
- Beta
- 0.39
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.18%
- Revenue (TTM)
- 264.44M
- Revenue growth
- 2.50%
- Free cash flow
- 8.11M
- Total cash
- 11.72M
- Total debt
- 14.00M
- Return on equity
- 0.20%
- Shares outstanding
- 14.42M
- Short % of float
- 2.05%
- 50-day average
- 49.39
- 200-day average
- 42.89
Analyst view
Consensus: hold
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 20, 2018
Expected Feb 20, 2018. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 20, 2018 | Dec 1, 2017 | 0.00 | — | — | — |
| Oct 30, 2017 | Sep 1, 2017 | 0.23 | — | — | — |
| Jul 27, 2017 | Jun 1, 2017 | 0.33 | — | — | — |
| Apr 25, 2017 | Mar 1, 2017 | 0.31 | — | — | — |
| Feb 21, 2017 | Dec 1, 2016 | 0.31 | — | — | — |
| Oct 31, 2016 | Sep 1, 2016 | 0.22 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 12, 2016 | Baird | up | — | Outperform |
| May 13, 2015 | Northland Securities | init | — | Market Perform |
| Apr 29, 2015 | Canaccord Genuity | down | — | Hold |
| Mar 18, 2015 | Gabelli & Co. | init | — | Buy |
| May 17, 2012 | Benchmark | init | — | Buy |
About Exactech, Inc.
Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services. It offers extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and knee system that provides solutions for partial, primary, and revision total knee arthroplasty. The company also provides hip solutions that address hip arthroplasty, reconstruction, and fractures, as well as primary hip surgeries. In addition, it offers biologics and spine products for the healing and regeneration of bone and soft tissues; and markets a platform of demineralized bone matrix products under the brand name Optecure, as well as OpteMx, a tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. Further, the company provides Accelerate, a platelet concentrating system that offers high platelet yields through centrifugal action; distribute Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; and Ossilix, a calcium phosphate bone cement indicated for filling bony defects in cancellous bone. Additionally, it offers Cemex Genta, a bone cement containing antibiotics; Cemex Fast, a cement with or without antibiotic; the InterSpace hip, knee, and shoulder spacers; and AcuDriver Automated Osteotome System, an air-driven impact handpiece that surgeons use during joint implant revision procedures to remove failed prostheses and bone cement. The company markets its orthopedic implant products through a network of independent sales agencies and distributors, direct sales representatives, and subsidiaries to hospitals, surgeons and other physicians, and clinics in the United States and internationally. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida.
- Sector
- Healthcare
- Industry
- Medical Appliances & Equipment
- Country
- United States
- Website
- exac.com
News
- Mid-Morning Market Update: U.S. Markets Mixed; Halliburton Beats Q3 Estimates
- Exactech Comments on Impact of Hurricanes Irma and Harvey; Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call
- Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call
- Exactech Schedules First Quarter 2017 Earnings Release and Conference Call
- Exactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
- Exactech Schedules Third Quarter 2016 Earnings Release and Conference Call
- Exactech Schedules Second Quarter 2016 Earnings Release and Conference Call
- Exactech Schedules First Quarter 2016 Earnings Release and Conference Call
- Exactech Schedules Fourth Quarter and Year End 2015 Earnings Release and Conference Call
- Exactech Announces Third Quarter 2015 Earnings Release Date and Updates Third Quarter Estimates
Your note
Sign in to keep a note on EXAC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BINCH JAMES G | Director | Sale | Feb 13, 2018 | 0 |
| EDWARDS DONNA M | Officer | Sale | Feb 13, 2018 | 0 |
| KRUSEN W ANDREW JR | Director | Sale | Feb 13, 2018 | 0 |
| LOCANDER WILLIAM B | Director | Sale | Feb 13, 2018 | 0 |
| MILLER GARY J | Officer | Sale | Feb 13, 2018 | 0 |
| PETTY BETTY A | Officer | Sale | Feb 13, 2018 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dimensional Fund Advisors LP | 6.16% | 888,228 | 44.01M | Dec 30, 2017 |
| Blackrock Inc. | 5.95% | 857,842 | 42.51M | Dec 30, 2017 |
| Gamco Investors Inc | 5.30% | 764,508 | 37.88M | Dec 30, 2017 |
| Gabelli Funds, LLC | 4.87% | 701,748 | 34.77M | Dec 30, 2017 |
| Water Island Capital, LLC | 3.75% | 541,395 | 26.83M | Dec 30, 2017 |
| Vanguard Group, Inc. (The) | 3.58% | 515,730 | 25.55M | Dec 30, 2017 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| EQ Advisors Trust-1290 VT Gamco Small Company Value Port | 2.08% | 300,000 | 9.03M | Jun 29, 2017 |
| DFA U.S. Small Cap Value Series | 1.73% | 249,604 | 7.54M | Jul 30, 2017 |
| iShares Russell 2000 ETF | 1.50% | 216,538 | 10.73M | Dec 30, 2017 |
| Teton Westwood Mighty Mites Fd | 1.48% | 213,400 | 10.57M | Dec 30, 2017 |
| Gabelli Small Cap Growth Fund | 1.46% | 210,024 | 10.41M | Dec 30, 2017 |
| Vanguard Total Stock Market Index Fund | 1.40% | 202,002 | 6.08M | Jun 29, 2017 |